Marine Drugs (May 2021)

Total Synthesis and Anti-Inflammatory Bioactivity of (−)-Majusculoic Acid and Its Derivatives

  • Hong-Xiu Xiao,
  • Qing-Xiang Yan,
  • Zhi-Hui He,
  • Zheng-Biao Zou,
  • Qing-Qing Le,
  • Ting-Ting Chen,
  • Bing Cai,
  • Xian-Wen Yang,
  • Su-Lan Luo

DOI
https://doi.org/10.3390/md19060288
Journal volume & issue
Vol. 19, no. 6
p. 288

Abstract

Read online

The first total synthesis of marine natural product, (−)-majusculoic acid (1) and its seven analogs (9–15), was accomplished in three to ten steps with a yield of 3% to 28%. The strategy featured the application of the conformational controlled establishment of the trans-cyclopropane and stereochemical controlled bromo-olefination or olefination by Horner–Wadsworth–Emmons (HWE) reaction. The potential anti-inflammatory activity of the eight compounds (1 and 9–15) was evaluated by determining the nitric oxide (NO) production in the lipopolysaccharide (LPS)-induced mouse macrophages RAW264.7. (−)-Majusculoic acid (1), methyl majusculoate (9), and (1R,2R)-2-((3E,5Z)-6-bromonona-3,5-dien-1-yl)cyclopropane-1-carboxylic acid (12) showed significant effect with inhibition rates of 33.68%, 35.75%, and 43.01%, respectively. Moreover, they did not show cytotoxicity against RAW264.7 cells, indicating that they might be potential anti-inflammatory agents.

Keywords